Andrew Kang

CFO Andrew Kang sold 33,062 shares ($3.9M) via 12 transactions on 2026-06-05 under 10b5-1 plan

Andrew Kang (EVP & CFO) executed 12 separate sales totaling 33,062 shares for $3,925,352.97 at prices ranging from $114.79 to $125.14 on 2026-06-05, reducing his non-derivative holdings by 32.5% to 68,733 shares. This transaction is part of a pre-arranged 10b5-1 trading plan and therefore reflects a scheduled divestment rather than discretionary decision-making. The company reported a net loss of $-12,542,670,000.00 in its most recent full fiscal year, and his five prior sales at MSTR registered 30-day and 90-day returns of -22.0%, -16.0%, -15.0%, -13.9%, and -15.2% respectively. The stock is currently trading 73.7% below its 52-week high of $457.22 and has declined 35.5% over the past 30 days.

CFO Kang Andrew sold 5,597 shares of MSTR at $165.78 under 10b5-1 plan; stock down 63.7% from 52-week high

Kang Andrew, EVP & CFO, sold 5,597 shares on 2026-05-19 at $165.78 for $927,865.06 as part of a pre-arranged 10b5-1 trading plan, reducing holdings from 39,272 to 33,675 shares. The stock trades at $165.81 currently, -63.7% from its 52-week high of $457.22. Strategy Inc reported $124,300,000 in latest-quarter revenue but a $-12,542,670,000 net loss and was unprofitable over its most recent full fiscal year. His prior same-ticker trades at MSTR (four sales in August 2025 and one buy in July 2025) were followed by 30-day and 90-day declines ranging from -13.9% to -16.0% for the sales, while the buy returned +276.5% over 30 days and +228.5% over 90 days. This execution is scheduled under a 10b5-1 plan rather than discretionary.

CFO Andrew Kang sells 18,750 MSTR shares for $7.4M at $390.00–$400.00; reduces holdings by 43.4% in 3 separate sales

Andrew Kang, EVP & CFO of MSTR, executed 3 separate sales on 2025-08-07 totaling 18,750 shares (18.8K shares) for $7,406,250.00 ($7.4M) at a blended average price of $395.00, reducing his holdings from 43,210 shares (43.2K shares) to 24,460 shares (24.5K shares)—a 43.4% reduction in post-transaction holdings. The stock is currently priced at $400.25, down 15.5% from its 52-week high of $473.83 and down 7.9% over 30 days. This is Kang's second sale in 2 days (following a 2025-08-05 sale) and part of a recent pattern of 3 sells at MSTR on 2025-06-06. His cross-ticker track record shows 17 prior sells with an average 90-day return of +23.9% (a 0.00% well-timed rate, indicating his prior sales have not preceded declines), though his 3 prior buys averaged a 90-day return of +334.2% with a 100% win rate. The fundamental backdrop shows annual revenue declined 6.6% year-over-year, the company reported a negative full-year net income despite a latest-quarter net income of $10,020,846,000.00, and recent quarterly revenue was $114,488,000.00. The magnitude of the sale and the sharp holding reduction deserve investor scrutiny given the company's deteriorating top-line growth and historical profitability concerns.

CFO Kang Andrew sold 6,250 shares of MSTR at $386.32 on 2025-08-05 for $2.4M, reducing stake by 20.4%

Kang Andrew, EVP & CFO of MicroStrategy, executed an open-market sale of 6,250 shares at $386.32, reducing his holdings from 30,710 shares to 24,460 shares (a 20.4% reduction). The sale occurred at a price 3.8% below the current market price of $402.01 and well below the 52-week high of $473.83. At the cross-ticker level, his prior sells have shown poor timing (average 90-day return of +12.2%, with 0% well-timed rate), though this specific ticker has only one measurable prior sale outcome (a +7.1% 30-day return from the June 2025 sale). The company faces headwinds—revenue contracted 6.6% year-over-year and full-year net income was negative—creating a backdrop of operational challenge against which a substantial reduction in insider equity requires attention.

CFO Andrew Kang buys 2,800 MSTR shares at $90.00 ($252K); part of 6-insider cluster buy within 14 days

Andrew Kang, EVP & CFO, purchased 2,800 shares at $90.00 on 2025-07-29, representing his first MSTR buy (prior position was zero). This purchase occurs within a 14-day cluster window in which 6 other insiders also bought, suggesting coordinated confidence at this price level. However, the company's fundamentals remain challenged: most recent quarterly revenue is $111.1M with a net loss of $-4.2B, and annual revenue has contracted -6.6% year-over-year. The stock now trades at $394.66, 76.7% above Kang's purchase price; his cross-ticker buy track record shows a 100% 90-day win rate with avg 90d return +334.2%, but his MSTR-specific history (5 prior trades, all sales in June 2025) yielded returns of +7.0%–+9.0% on the 30-day measure with no measurable 90-day outcomes yet. The magnitude of the cluster buy pattern and the CFO's first-time participation warrant investor attention, though the company's persistent unprofitability and negative revenue growth remain material context.

MSTR CFO Kang bought 2,250 shares at $85.00 then sold 1,877 shares at $370.70–$377.14 same day; net +373 shares. Cluster buy pattern with 3 other insiders in 14 days.

Andrew Kang, EVP & CFO of MicroStrategy, purchased 2,250 shares at $85.00 on June 5, 2025, then executed 8 separate sales totaling 1,877 shares at prices ranging from $370.70 to $377.14 on June 6, 2025. The net effect is a modest long position increase of 373 shares, leaving him with 24,460 shares post-transaction. The purchase occurred at a price substantially below current levels ($392.12), and his same-ticker history shows three recent sells on May 20 with outcomes not yet measurable, followed by a March 24 sell that returned +4.9% over 30 days. A cluster buy pattern—3 other insiders also purchased within the past 14 days—suggests coordinated conviction among the leadership team. The company's fundamentals are challenged: unprofitable with -$4.2B net income over the most recent full fiscal year, annual revenue decline of -6.6%, and the stock is -17.2% from its 52-week high despite a +50.5% 90-day gain. This filing represents both an open-market purchase and multiple sales, with the net result showing residual bullish positioning from the CFO despite immediate profit-taking on a portion of shares.

CFO Andrew Kang sold 5,638 shares for $2.3M on 2025-05-20; stock at $402.69 vs. 52-week high of $473.83; company unprofitable with -6.6% annual revenue decline.

Andrew Kang, EVP & CFO, executed 4 separate sales totaling 5,638 shares (5.6K shares) for $2,312,794.62 ($2.3M) at blended average price of $410.22 on 2025-05-20, reducing his holdings by 20.3%. The timing follows the stock's surge from 90-day change of +24.3% and 30-day change of +26.7%, though the current price of $402.69 now sits 15.0% below the 52-week high of $473.83. The company's fundamentals remain challenged: latest quarterly revenue of $111,066,000.00 ($111.1M), annual revenue decline of -6.6%, and a full-year net loss of $-4,217,370,000.00 ($-4.2B) underscore ongoing operational difficulties. Kang's prior trades at MSTR have generated mixed outcomes—two recent sales in March saw 30-day returns of +4.9% and +5.1%, yet his cross-ticker track record shows 10 prior sells with an average 90-day return of -8.4% and a 90d well-timed rate of 37.50%, indicating that his sell timing has historically underperformed.

CFO Kang Andrew sold 2,185 shares for $719,441.00 at $329.26 avg price on 2025-03-24.

Andrew Kang, EVP & CFO of MicroStrategy, executed 2 separate sales on 2025-03-24 totaling 2,185 shares for $719,441.00, reducing his holdings by 12.6% from 17,400 to 15,215 shares. The blended average price of $329.26 is near the current price of $329.31, suggesting minimal subsequent price movement. His prior trades at MSTR show a poor timing pattern: 4 prior sales from 2024-11-06 generated strong 30-day returns (+51.7% to +53.6%) but all 4 produced positive 90-day returns (+33.8% to +35.4%), meaning the stock rose after he sold—outcomes indicating the insider did not sell in advance of declines. Contextually, MicroStrategy is unprofitable with a net loss of $-340,174,000.00 on quarterly revenue of $116,071,000.00 and annual revenue decline of -6.6%, yet the stock is up 16.5% over 30 days despite being -30.5% from its 52-week high of $473.83, creating significant recent momentum. The timing of this sale—following a sharp 4-day buy on 2025-03-20 and coinciding with strong near-term price recovery—warrants closer scrutiny of whether fundamentals or liquidity drove the decision.

CFO Kang Andrew bought 1,500 shares of MSTR at $85.00 (now $335.72); 2 other insiders bought within 14 days despite -$340.2M net income.

Kang Andrew, EVP & CFO of MicroStrategy, purchased 1,500 shares at $85.00 on 2025-03-20 in a cluster pattern with 2 other insiders buying within the past 14 days, suggesting coordinated confidence during a volatile period. However, this buy occurs amid challenging fundamentals: the company reported net income of -$340.2M over its most recent full fiscal year and annual revenue growth of -6.6%. The stock has appreciated significantly since the transaction ($335.72 current price vs $85.00 purchase), but his prior MSTR-specific sells have been poorly timed—all 3 measurable prior sales at this ticker showed positive 90-day returns (ranging from +35.2% to +36.1%), meaning he sold before subsequent rallies. His cross-ticker track record shows a 37.50% well-timed sell rate, suggesting below-average timing skill on open-market exits. The cluster buy pattern does indicate multiple insiders acted, but in the context of persistent unprofitability and a mixed trading history at this ticker, the signal warrants scrutiny of whether this reflects genuine operational confidence or other motivations.

MSTR CFO Andrew Kang sells 5,700 shares for $1.5M as stock hits 52-week high; 3 prior MSTR sells at this timepoint were -80%+ underwater 90 days later.

Kang Andrew (SEVP & CFO) executed 5 separate sales totaling 5,700 shares for $1,465,766.20 on 2024-11-06, reducing his holdings by 32.1% from 17,780 to 12,080 shares. The sales occurred as MSTR trades at $270.42, within 0.1% of its 52-week high of $270.81, and coinciding with the stock's 43.2% gain in the preceding 30 days and 99.8% gain over 90 days. His prior trading history at MSTR is notably consistent: three earlier sales executed on 2024-02-27 (dates of peak valuation in that prior cycle) subsequently saw the stock decline approximately 80% in the 90-day period following each sale. This current filing does not carry a 10b5-1 flag, so timing remains a valid observation. Against this backdrop of a company posting negative net income of $-340,174,000.00, flat annual revenue growth of -0.6%, and a CFO disposing of a substantial open-market stake near a technical peak, the filing warrants attention to whether this signals end-of-rally conviction or routine rebalancing.